As of 2025-10-30, the EV/EBITDA ratio of Gritstone Oncology Inc (GRTS) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GRTS's latest enterprise value is -8.76 mil USD. GRTS's TTM EBITDA according to its financial statements is -124.44 mil USD. Dividing these 2 quantities gives us the above GRTS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 15.2x | 13.8x |
| Forward P/E multiples | 20.1x - 43.4x | 31.8x |
| Fair Price | (49.21) - (37.16) | (55.78) |
| Upside | -152915.4% - -115506.4% | -173337.6% |
| Date | EV/EBITDA |